Congenital Anomalies of the Kidney and Urinary Tract (CAKUT)

Congenital anomalies of the kidney and urinary tract (CAKUT) encompass a wide phenotypic spectrum of structural malformations resulting from defects in embryonic renal and urinary tract development.
The spectrum includes renal aplasia (absence of the kidney), renal dysplasia (failure of normal renal differentiation), renal hypoplasia (smaller kidneys), hydronephrosis, vesicoureteral reflux (VUR), posterior urethral valves (PUV), and duplicated collecting systems.
CAKUT accounts for approximately 25–30% of all cases of chronic kidney disease (CKD) and represents the leading cause of end-stage kidney disease (ESKD) in the pediatric population.

The development of the mammalian kidney relies on the precise, spatially and temporally regulated interaction between the ureteric bud and the metanephric mesenchyme.
Genetic architecture is highly heterogeneous, demonstrating variable expressivity and incomplete penetrance, frequently involving mutations in transcription factors or signaling molecules.
Key developmental pathways implicated include the renin-angiotensin system (e.g., AGTR2), receptor tyrosine kinase signaling (e.g., RET, GDNF), Wnt, Hedgehog, and retinoic acid signaling pathways.
HNF1B mutations represent the most common monogenic cause of CAKUT, particularly associated with multicystic dysplastic kidneys (MCDK), renal cysts, and maturity-onset diabetes of the young (MODY 5).
CAKUT is frequently a component of multiorgan genetic syndromes, including Branchio-Oto-Renal syndrome (EYA1, SIX1), Townes-Brocks syndrome, Alagille syndrome (JAGGED1), and CAKUTHED syndrome (PBX1).
Chromosomal anomalies, particularly Trisomy 13, 18, and 21, are relatively common causes of syndromic CAKUT.

Environmental/In Utero Risk Factors	Associated CAKUT Phenotype
ACE Inhibitors / ARBs	Renal tubular dysgenesis (absence of proximal tubules, skull ossification defects).
Maternal Hyperglycemia / Diabetes	Renal agenesis, horseshoe kidney, cystic dysplasia, PUV, and hydronephrosis.
Alcohol	Agenesis, ectopia, cystic dysplasia, hydronephrosis (potentially via altered retinoic acid metabolism).
Cocaine	Renal agenesis and hypoplasia (likely due to severe uteroplacental vasoconstriction).
Folic Acid Antagonists (e.g., Valproate)	Associated with a higher incidence of urinary tract malformations.

Antenatal Presentation: CAKUT is most frequently identified during routine second-trimester (20–22 weeks) transabdominal ultrasonography as antenatal hydronephrosis, altered renal echogenicity, or abnormal amniotic fluid volume.
Renal Oligohydramnios (ROH): Severe bilateral CAKUT (e.g., bilateral renal agenesis or PUV) causes a critical lack of fetal urine production, leading to oligohydramnios or anhydramnios.
Potter Sequence: The physical compression and lack of amniotic fluid secondary to ROH leads to severe pulmonary hypoplasia (the primary cause of mortality), characteristic flattened Potter facies, limb deformities, and perinatal asphyxia.
Postnatal Presentation: Patients frequently present with recurrent, febrile urinary tract infections (UTIs).
Other postnatal manifestations include a palpable abdominal mass (e.g., massive hydronephrosis or MCDK), voiding dysfunction, secondary hypertension, and signs of progressive CKD such as growth failure and anemia.

Antenatal Ultrasound: Utilizes the Urinary Tract Dilation (UTD) risk stratification system (A1 vs. A2-3) based on the anterior-posterior renal pelvic diameter (APRPD), calyceal dilation, parenchymal thickness, and bladder abnormalities to predict postnatal outcomes.
Postnatal Ultrasound: The initial radiological investigation of choice to assess kidney size, corticomedullary differentiation, presence of cysts, and to grade the severity of hydro(uretero)nephrosis.

Advanced Imaging Modality	Clinical Indications and Findings
Voiding Cystourethrogram (VCUG)	The gold standard for diagnosing vesicoureteral reflux (VUR) and posterior urethral valves (PUV). It evaluates bladder morphology, capacity, and urethral patency.
$^{99 m}$ Tc-MAG3 Diuretic Renogram	The preferred study for evaluating suspected urinary tract obstruction (e.g., pelviureteric junction obstruction) and estimating split renal function, relying on tracer washout half-time after furosemide administration.
$^{99 m}$ Tc-DMSA Cortical Scintigraphy	The radiotracer of choice for high-resolution imaging of the renal cortex. It is highly sensitive for detecting parenchymal scarring (reflux nephropathy) and confirming functional renal dysplasia.

Antenatal Intervention: In highly selected cases of severe lower urinary tract obstruction (e.g., PUV) causing ROH, interventions such as vesicoamniotic shunting or serial amnioinfusions may be offered to preserve lung development and mitigate pulmonary hypoplasia.
Antimicrobial Prophylaxis: Indicated for the prevention of recurrent febrile UTIs in patients with high-grade VUR (Grades III-V), or in uncircumcised male infants with prenatal hydronephrosis and VUR.
Surgical Intervention:
- Primary endoscopic valve ablation is the definitive treatment for posterior urethral valves; cutaneous vesicostomy may be required in small infants where ablation is not feasible.
- Dismembered pyeloplasty is indicated for severe or progressively worsening ureteropelvic junction obstruction demonstrating poor drainage and declining split renal function on MAG-3 scans.
- Ureteral reimplantation is reserved for persistent, high-grade VUR associated with breakthrough infections or progressive renal scarring.
CKD Management: Aggressive supportive care to delay ESKD progression involves maintaining blood pressure targets (often utilizing RAAS blockade to minimize proteinuria), optimizing nutrition (providing 100% of estimated energy requirements without protein restriction), and managing mineral bone disease (CKD-MBD).